Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma - Archive ouverte HAL Access content directly
Journal Articles Bone Marrow Transplantation Year : 2002

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma

C Thieblemont
  • Function : Author
C Dumontet
  • Function : Author
H Saad
  • Function : Author
N Roch
  • Function : Author
F Bouafia
  • Function : Author
P Arnaud
  • Function : Author
O Hequet
  • Function : Author
D Espinouse
  • Function : Author
G Salles
  • Function : Author
A Eljaafari-Corbin
  • Function : Author
C Du Manoir-Baumgarten
  • Function : Author
B Coiffier
  • Function : Author
No file

Dates and versions

hal-04153223 , version 1 (06-07-2023)

Identifiers

Cite

C Thieblemont, C Dumontet, H Saad, N Roch, F Bouafia, et al.. Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. Bone Marrow Transplantation, 2002, 30 (11), pp.769-775. ⟨10.1038/sj.bmt.1703757⟩. ⟨hal-04153223⟩

Collections

HCL
5 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More